Inderjit Mehmi

Inhibition of fatty acid synthase (FAS) suppresses <i>HER2/neu</i> ( <i>erb</i> B-2) oncogene overexpression in cancer cells

Javier A. Menéndez, Luciano Vellón, Inderjit Mehmi et al. · Proceedings of the National Academy of Sciences · 2004 · 325 citations · Full text

Medicine, Molecular Biology, Oncology +16

A novel CYR61-triggered ‘CYR61-αvβ3 integrin loop’ regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway

Javier A. Menéndez, Luciano Vellón, Inderjit Mehmi et al. · Oncogene · 2004 · 153 citations

Life Sciences, Cell Biology, Oncology +14

Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer

Miaw-Sheue Tsai, Lisa A. Shamon-Taylor, Inderjit Mehmi et al. · Oncogene · 2003 · 119 citations

Medicine, Cancer Biology, Oncology +14

Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.

Ella Atlas, Marina Cardillo, Inderjit Mehmi et al. · PubMed · 2003 · 113 citations · Full text

Medicine, Molecular Biology, Oncology +16

Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-κB

Javier A. Menéndez, Inderjit Mehmi, Ella Atlas et al. · International Journal of Oncology · 2004 · 112 citations

Life Sciences, Cell Biology, Oncology +17